High Dose Seasonal Influenza Vaccine Specifically Intended For People Ages 65 And Older Approved By U.S. FDA

The U.S. Food as well as Drug Administration currently authorized Fluzone High-Dose, an inactivated influenza pathogen vaccine for people ages 65 years as well as older to prevent disease caused by influenza pathogen subtypes A as well as B. People in this age organisation are at highest risk for seasonal influenza complications, that might outcome in hospitalization as well as death...